Clinical Trial

A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to find out if UBT251 is safe and effective for treating people who are living with overweight or obesity. Participants will get either UBT251 (the treatment being tested) or Placebo (a treatment that has no active medicine in it), which treatment participants get is decided by chance.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-02-01; most recent amendment 2026-04-20.
Status change: Not Yet Recruiting → Recruiting 2026-02-16
Trial Details
NCT Number NCT07395687
Lead Sponsor Novo Nordisk A/S
Conditions Overweight, Obesity
Enrollment 333 participants
Start Date 2026-02-02
Primary Completion 2027-01-14 (estimated)
Study Completion 2027-02-18 (estimated)
Updated on ClinicalTrials.gov 2026-04-21